Enter Note Done

Session


S. Pidot: H. Research Contractor; Self; Spero Therapeutics. T. Stinear: H. Research Contractor; Self; Spero Therapeutics. T. Lister: D. Employee; Self; Spero Therapeutics. K. Shareholder (excluding diversified mutual funds); Self; Spero Therapeutics. A. Rubio: C. Consultant; Self; Spero Therapeutics. D. Employee; Self; Spero Therapeutics. K. Shareholder (excluding diversified mutual funds); Self; Spero Therapeutics.

S. Pidot{1}, T. Stinear{1}, T. Lister{2}, A. Rubio{2}; {1}Univ. of Melbourne, Melbourne, Australia, {2}Spero Therapeutics, Cambridge, MA
Track
Antimicrobial Agents and Resistance
Subtrack
AAR08 - New Antimicrobial Agents
AAR09 - Pharmacological Studies of Investigational Agents Pre-NDA
Course Level
Intermediate
Session Type
Symposium
Curated Itineraries
New Agents in Pipeline